News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Bethel Adefres: The 2024 World Congress of Brachytherapy
Photo from Bethel Adefres/X
Jul 24, 2024, 00:56

Bethel Adefres: The 2024 World Congress of Brachytherapy

Bethel Adefres, Radiation Oncologist at Yale University, shared on X:

“Last week at the 2024 World Congress of brachytherapy with mentors and friends, working together to raise awareness and advance this vital cancer treatment.”

Bethel Adefres

Source: Bethel Adefres/X

2024 World Congress of Brachytherapy Bethel Adefres cancer OncoDaily Oncology radiation oncology Yale University
Blog
Jul 24, 2024, 07:20
Ruben Mesa: Medical Physics trainees their data to travelers at SAT airport
Blog
Jul 24, 2024, 07:13
Mu-Han Lin: Nina Niu Sanford presenting Clinical Advances in GI at the AAPM-ASTRO Highlights of Clinical Trials
Blog
Jul 24, 2024, 06:52
Douglas Flora: Launching the Faith Community Pharmacy Provider Network in Northern Kentucky
Blog
Jul 24, 2024, 06:43
Ravindran Kanesvaran: Privileged to speak at ANZUP Cancer Trials Group Limited annual meeting
Dialogues
Jul 24, 2024, 06:42
TRANSiTION - Training Opportunity in Digital Health: Interview with Andreas Charalambous
Blog
Jul 24, 2024, 06:20
Naveen Pemmaraju: Co-chairing the inaugural International Workshop on MPN24 meeting
Blog
Jul 24, 2024, 06:16
Shushan Hovsepyan: Five open grant opportunities for pediatric oncologists
Blog
Jul 24, 2024, 05:00
Clinical Validation of a Cell-free DNA assay for Early Lung Cancer Detection
Blog
Jul 24, 2024, 04:49
IGCS training visit in Zambia
Blog
Jul 24, 2024, 04:09
Boosting Childhood Cancer Survival in Nigeria with Look Again Program by Dorcas Cancer Foundation
Blog
Jul 24, 2024, 03:52
Isabel Preeshagul: Take home from Lung Cancer Summit
Insight
Jul 24, 2024, 03:52
Piotr Wysocki: The type of immunotherapy-related adverse event significantly impacts the outcomes of patients undergoing anti-cancer immunotherapy